Sports Yonhap News Sports · 2026-11-02

European 1,500m Champion Ciara Mageean Passes Away at 34 After Battle with Colon Cancer

Key Points
  • Irish track star and 2024 European 1,500m gold medalist Ciara Mageean has died at age 34 after battling stage four colon cancer.
  • Korean sports media spotlighted her passing, mourning an inspiring figure who shared hope with cancer patients until the very end.
  • Mageean was a revered pillar of Irish athletics who overcame career-threatening injuries in 2013 to reach the peak of international distance running.
Summary Irish middle-distance runner Ciara Mageean, who captured gold in the women's 1,500 meters at the 2024 European Athletics Championships, has passed away at the age of 34 after battling colon cancer. According to reports from BBC and international sports outlets cited by South Korean media on November 2, Mageean was diagnosed with stage four colorectal cancer in May of last year. Despite the grave prognosis, she remained a beloved figure and a beacon of resilience, maintaining an active public presence to offer hope, courage, and solidarity to cancer patients around the world. Just last month, she celebrated a deeply meaningful milestone by marrying her longtime partner, Thomas Moran. Mageean was widely recognized as the defining face of Irish women's athletics. She first rose to international prominence after clinching a silver medal in the 1,500 meters at the 2010 World Junior Athletics Championships. Although ankle injuries temporarily derailed her early senior career, she underwent surgery in 2013 and mounted an inspiring resurgence, steadily establishing herself on podiums across prestigious international events. Her passing has prompted a wave of emotional tributes from athletics federations and sports communities globally. Korean news outlets highlighted both her athletic triumphs and her inspiring courage in the face of terminal illness, celebrating a life that touched athletes and ordinary fans far beyond the borders of track and field.
Sponsored · Ad